Cargando…
Challenges in Drug Discovery for Intracellular Bacteria
Novel drugs are needed to treat a variety of persistent diseases caused by intracellular bacterial pathogens. Virulence pathways enable many functions required for the survival of these pathogens, including invasion, nutrient acquisition, and immune evasion. Inhibition of virulence pathways is an es...
Autores principales: | Tucker, Allison N., Carlson, Travis J., Sarkar, Aurijit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468363/ https://www.ncbi.nlm.nih.gov/pubmed/34578204 http://dx.doi.org/10.3390/pathogens10091172 |
Ejemplares similares
-
The Next Opportunity in Anti-Malaria Drug Discovery: The Liver Stage
por: Derbyshire, Emily R., et al.
Publicado: (2011) -
Photobactericides—A Local Option against Multi-Drug Resistant Bacteria
por: Wainwright, Mark, et al.
Publicado: (2013) -
Open drug discovery for the Zika virus
por: Ekins, Sean, et al.
Publicado: (2016) -
Challenges to replace ACT as first-line drug
por: Phyo, Aung Pyae, et al.
Publicado: (2017) -
Drug-resistant tuberculosis control in China: progress and challenges
por: Long, Qian, et al.
Publicado: (2016)